» Articles » PMID: 3172645

Extra-renal Production of Calcitriol in Chronic Renal Failure

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1988 Sep 1
PMID 3172645
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Renal 1-alpha-hydroxylase activity is tightly regulated in normal humans and intact animals. No significant changes in serum 1,25(OH)2D levels occur in response to vitamin D challenge. However, conflicting reports have appeared in the literature with regard to stimulation of 1,25(OH)2D production after 25(OH)D administration in uremia. To provide further insight into this issue, 25(OH)D at a dose of 100 micrograms every other day for two weeks followed by 50 micrograms every other day for the next two weeks was given orally to seven uremic mongrel dogs. After two weeks of 25(OH)D therapy, 1,25(OH)2D levels increased from 16.4 +/- 0.9 to 28.0 +/- 1.9 pg/ml (P less than 0.001) in parallel with a fourfold increase in 25(OH)D concentrations from a basal of 50.1 +/- 6.5 to 203.2 +/- 18.1 ng/ml. No significant changes in serum i-PTH, ICa or P were observed. Linear regression analysis of the relationship between serum concentrations of 1,25(OH)2D versus 25(OH)D, for each dog during this period, showed highly significant correlation coefficients. To evaluate the possibility that extra-renal sites contribute to the described enhanced 1,25(OH)2D net synthesis after 25(OH)D treatment, similar studies were performed in four anephric patients undergoing hemodialysis. Basal serum 1,25(OH)2D levels were 5.5 +/- 2.4 pg/ml and increased to 19.6 +/- 5.0 pg/ml after 25(OH)D administration. A significant correlation was also found for the relationship between serum levels of 1,25(OH)2D and 25(OH)D in anephrics (r = 0.72, P less than 0.001). The same therapy in four normal volunteers showed no significant changes in serum 1,25(OH)2D concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

The effects and safety of high dose vitamin D3 in hemodialysis patients.

Guella A, Abduelkarem A, Hassanein M Pharm Pract (Granada). 2023; 21(1):2773.

PMID: 37090466 PMC: 10117363. DOI: 10.18549/PharmPract.2023.1.2773.


The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease.

Pistis K, Westerberg P, Qureshi A, Beshara S, Sterner G, Barany P BMC Nephrol. 2023; 24(1):20.

PMID: 36698076 PMC: 9875529. DOI: 10.1186/s12882-022-03014-z.


Parameters of Vitamin D Metabolism in Patients with Hypoparathyroidism.

Zhukov A, Povaliaeva A, Abilov Z, Kovaleva E, Usoltseva L, Eremkina A Metabolites. 2022; 12(12).

PMID: 36557317 PMC: 9782652. DOI: 10.3390/metabo12121279.


Effect of calcifediol supplementation on renin-angiotensin-aldosterone system mediators in dogs with chronic kidney disease.

Miller M, Quimby J, Langston C, Ames M, Parker V J Vet Intern Med. 2022; 36(5):1693-1699.

PMID: 35962709 PMC: 9511075. DOI: 10.1111/jvim.16499.


Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.

Bishop C, Strugnell S, Csomor P, Kaiser E, Ashfaq A Am J Nephrol. 2022; 53(6):446-454.

PMID: 35551374 PMC: 9393814. DOI: 10.1159/000524289.